Inventor · disambiguated record
Sean M. Rafferty
Also filed as: RAFFERTY SEAN · RAFFERTY SEAN M
2 granted patents·7 pending applications·15 citations·filing 2021–2025
53Inventor score
Files withENANTA PHARM INC9
Top patents by PatentIndex Score
9 records- 0195US11358953B2Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 14, 2022·15 cites·10 claims
- 0268US2022041652A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 0367US2022033383A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 0461US2024325409A1Fused Heterotetracyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0560US2024368096A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0658US12145941B2Heterocyclic antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 19, 2024·0 cites·14 claims
- 0758US2024140922A1Fused heterobicyclic antiviral agentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 0854US2022048944A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 0945US2025304542A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean M. Rafferty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →